159 related articles for article (PubMed ID: 29477386)
1. Visualisation of intracellular production bottlenecks in suspension-adapted CHO cells producing complex biopharmaceuticals using fluorescence microscopy.
Mathias S; Fischer S; Handrick R; Fieder J; Schulz P; Bradl H; Gorr I; Gamer M; Otte K
J Biotechnol; 2018 Apr; 271():47-55. PubMed ID: 29477386
[TBL] [Abstract][Full Text] [Related]
2. Analysis of intracellular IgG secretion in Chinese hamster ovary cells to improve IgG production.
Kaneyoshi K; Uchiyama K; Onitsuka M; Yamano N; Koga Y; Omasa T
J Biosci Bioeng; 2019 Jan; 127(1):107-113. PubMed ID: 30017708
[TBL] [Abstract][Full Text] [Related]
3. miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development.
Fischer S; Marquart KF; Pieper LA; Fieder J; Gamer M; Gorr I; Schulz P; Bradl H
Biotechnol Bioeng; 2017 Jul; 114(7):1495-1510. PubMed ID: 28262952
[TBL] [Abstract][Full Text] [Related]
4. Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production.
Budge JD; Knight TJ; Povey J; Roobol J; Brown IR; Singh G; Dean A; Turner S; Jaques CM; Young RJ; Racher AJ; Smales CM
Metab Eng; 2020 Jan; 57():203-216. PubMed ID: 31805379
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic Reticulum-Associated rht-PA Processing in CHO Cells: Influence of Mild Hypothermia and Specific Growth Rates in Batch and Chemostat Cultures.
Vergara M; Berrios J; Martínez I; Díaz-Barrera A; Acevedo C; Reyes JG; Gonzalez R; Altamirano C
PLoS One; 2015; 10(12):e0144224. PubMed ID: 26659083
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of Chinese hamster ovary cells towards enhanced protein secretion.
Torres M; Dickson AJ
Metab Eng; 2022 Jan; 69():249-261. PubMed ID: 34929420
[TBL] [Abstract][Full Text] [Related]
7. Unraveling what makes a monoclonal antibody difficult-to-express: From intracellular accumulation to incomplete folding and degradation via ERAD.
Mathias S; Wippermann A; Raab N; Zeh N; Handrick R; Gorr I; Schulz P; Fischer S; Gamer M; Otte K
Biotechnol Bioeng; 2020 Jan; 117(1):5-16. PubMed ID: 31631329
[TBL] [Abstract][Full Text] [Related]
8. miRNA profiling of high, low and non-producing CHO cells during biphasic fed-batch cultivation reveals process relevant targets for host cell engineering.
Stiefel F; Fischer S; Sczyrba A; Otte K; Hesse F
J Biotechnol; 2016 May; 225():31-43. PubMed ID: 27002234
[TBL] [Abstract][Full Text] [Related]
9. An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes.
Becker E; Florin L; Pfizenmaier K; Kaufmann H
J Biotechnol; 2008 Jun; 135(2):217-23. PubMed ID: 18448183
[TBL] [Abstract][Full Text] [Related]
10. Culture temperature modulates half antibody and aggregate formation in a Chinese hamster ovary cell line expressing a bispecific antibody.
Gomez N; Wieczorek A; Lu F; Bruno R; Diaz L; Agrawal NJ; Daris K
Biotechnol Bioeng; 2018 Dec; 115(12):2930-2940. PubMed ID: 30036451
[TBL] [Abstract][Full Text] [Related]
11. Improving the secretory capacity of Chinese hamster ovary cells by ectopic expression of effector genes: Lessons learned and future directions.
Hansen HG; Pristovšek N; Kildegaard HF; Lee GM
Biotechnol Adv; 2017; 35(1):64-76. PubMed ID: 27931938
[TBL] [Abstract][Full Text] [Related]
12. Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.
Sinharoy P; Aziz AH; Majewska NI; Ahuja S; Handlogten MW
Sci Rep; 2020 Oct; 10(1):16620. PubMed ID: 33024175
[TBL] [Abstract][Full Text] [Related]
13. Application of a curated genome-scale metabolic model of CHO DG44 to an industrial fed-batch process.
Calmels C; McCann A; Malphettes L; Andersen MR
Metab Eng; 2019 Jan; 51():9-19. PubMed ID: 30227251
[TBL] [Abstract][Full Text] [Related]
14. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
[TBL] [Abstract][Full Text] [Related]
16. Trehalose suppresses antibody aggregation during the culture of Chinese hamster ovary cells.
Onitsuka M; Tatsuzawa M; Asano R; Kumagai I; Shirai A; Maseda H; Omasa T
J Biosci Bioeng; 2014 May; 117(5):632-8. PubMed ID: 24315529
[TBL] [Abstract][Full Text] [Related]
17. The secretory pathway - the key for unlocking the potential of Chinese hamster ovary cell factories for manufacturing therapeutic proteins.
Torres M; Hussain H; Dickson AJ
Crit Rev Biotechnol; 2023 Jun; 43(4):628-645. PubMed ID: 35465810
[TBL] [Abstract][Full Text] [Related]
18. Improving the secretory capacity of CHO producer cells: The effect of controlled Blimp1 expression, a master transcription factor for plasma cells.
Kim SH; Baek M; Park S; Shin S; Lee JS; Lee GM
Metab Eng; 2022 Jan; 69():73-86. PubMed ID: 34775077
[TBL] [Abstract][Full Text] [Related]
19. Secretory pathway optimization of CHO producer cells by co-engineering of the mitosRNA-1978 target genes CerS2 and Tbc1D20.
Pieper LA; Strotbek M; Wenger T; Gamer M; Olayioye MA; Hausser A
Metab Eng; 2017 Mar; 40():69-79. PubMed ID: 28088541
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells.
Lu Y; Zhou Q; Han Q; Wu P; Zhang L; Zhu L; Weaver DT; Xu C; Zhang B
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6081-6093. PubMed ID: 29766242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
